1. Cell Cycle/DNA Damage
    Antibody-drug Conjugate/ADC Related
    Epigenetics
    Apoptosis
    Anti-infection
  2. Topoisomerase
    ADC Cytotoxin
    MicroRNA
    Influenza Virus
    Apoptosis
    Fungal
    Antibiotic
  3. Camptothecin

Camptothecin (Synonyms: Campathecin; (S)-(+)-Camptothecin; CPT)

Cat. No.: HY-16560 Purity: 99.69%
Handling Instructions

Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM. Camptothecin (CPT) exhibits powerful antineoplastic activity against colorectal, breast, lung and ovarian cancers, modulates hypoxia-inducible factor-1α (HIF-1α) activity by changing microRNAs (miRNA) expression patterns in human cancer cells.

For research use only. We do not sell to patients.

Camptothecin Chemical Structure

Camptothecin Chemical Structure

CAS No. : 7689-03-4

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply Now  
Solution
10 mM * 1 mL in DMSO USD 55 In-stock
Estimated Time of Arrival: December 31
Solid + Solvent
10 mM * 1 mL
ready for reconstitution
USD 55 In-stock
Estimated Time of Arrival: December 31
Solid
100 mg USD 50 In-stock
Estimated Time of Arrival: December 31
500 mg USD 150 In-stock
Estimated Time of Arrival: December 31
1 g   Get quote  
5 g   Get quote  

* Please select Quantity before adding items.

Customer Review

Based on 24 publication(s) in Google Scholar

Top Publications Citing Use of Products

    Camptothecin purchased from MCE. Usage Cited in: Nat Commun. 2018 Oct 8;9(1):4139.

    One hour after treated with UV or 2 h after treated with MMS, Camptothecin (CPT) (10 μM), or Doxorubicin (DOX; 0.5 μM), HEK293T cells expressing HA-SUMO2 and His-RhoB are subjected to sumoylation assay to detect the SUMO2 conjugation of RhoB.

    Camptothecin purchased from MCE. Usage Cited in: Nat Commun. 2019 Aug 21;10(1):3761.

    Genotoxic stress-induced β-catenin signaling is activated via a TCF- or FOXO-independent mechanism. Representative images of the subcellular localization of β-catenin in the indicated cells treated with CPT (10 μM, 1 h), IR (10 Gy), and CDDP (10 μM, 1 h), as analyzed by immunofluorescence staining.

    Camptothecin purchased from MCE. Usage Cited in: Cell Death Differ. 2020 Nov;27(11):3162-3176.

    293T cells transfected with Flag-TopBP1 and GFP-tagged RBMX and its domain (RRM, RBM1CTR, and C-RBD) are treated with 100 nM CPT for 24 h and subjected to immunoprecipitation with Flag-beads. Immunoprecipitates are immunoblotted with Flag and GFP antibodies, respectively.
    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM[1]. Camptothecin (CPT) exhibits powerful antineoplastic activity against colorectal, breast, lung and ovarian cancers, modulates hypoxia-inducible factor-1α (HIF-1α) activity by changing microRNAs (miRNA) expression patterns in human cancer cells[2][3].

    IC50 & Target[3]

    Topoisomerase I

    679 nM (IC50)

    Camptothecins

     

    In Vitro

    High TOP1 enzymatic activity MCF7 (Luminal subtype) and HCC1419 (HER2 subtype) show high sensitivity toward Camptothecin (0.1 μM to 5 μM; 72 hours) treatment, exhibiting the IC50 values of 0.089 μM and 0.067 μM, respectively[4].
    Camptothecin (0.5 μM; 6 and 24 hours) reduces desferrioxamine-activated VEGF expression.
    Camptothecin (0.5 μM; 8 to 24 hours) strongly prevents the desferrioxamine-dependent HIF-1a accumulation[2].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Cell Viability Assay[4]

    Cell Line: MCF7 (Luminal subtype) and HCC1419 (HER2 subtype)
    Concentration: 0.1 μM to 5 μM
    Incubation Time: 72 hours
    Result: High TOP1 enzymatic activity MCF7 (Luminal subtype) and HCC1419 (HER2 subtype) show high sensitivity toward CPT (0.1 μM to 5 μM; 72 hours) treatment, exhibiting the IC50 values of 0.089 μM and 0.067 μM, respectively.

    RT-PCR[2]

    Cell Line: HeLa and HEK293 cell lines
    Concentration: 0.5 μmol/L
    Incubation Time: 6 and 24 hours
    Result: Reduces desferrioxamine-activated VEGF expression in both cell lines after 6 and 24 hours of treatment, whereas in normoxic condition camptothecin does not affect the VEGF mRNA level.

    Western Blot Analysis[2]

    Cell Line: HeLa and HEK293 cell lines
    Concentration: 0.5 μmol/L
    Incubation Time: 8 to 24 hours
    Result: Strongly prevents the desferrioxamine-dependent HIF-1a accumulation after 8 to 24 hours, whereas it does not affect HIF-1b levels.
    In Vivo

    Camptothecin (2 mg/kg every other day) treats mice, has developed numerous pulmonary metastases.
    Treatment with both kinase inhibitor of nuclear factor-kappaB-1 (KINK-1) and Camptothecin led to a statistically significant reduction in the number of pulmonary metastases[5].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: C57BL6 mice (injected with B16F10 melanoma cells)[5]
    Dosage: 2 mg/kg
    Administration: every other day, after 19 days
    Result: Has developed numerous pulmonary metastases.
    Clinical Trial
    Molecular Weight

    348.35

    Formula

    C₂₀H₁₆N₂O₄

    CAS No.
    Shipping

    Room temperature in continental US; may vary elsewhere.

    Storage

    4°C, protect from light

    *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

    Solvent & Solubility
    In Vitro: 

    DMSO : 6.25 mg/mL (17.94 mM; Need ultrasonic)

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.8707 mL 14.3534 mL 28.7068 mL
    5 mM 0.5741 mL 2.8707 mL 5.7414 mL
    10 mM 0.2871 mL 1.4353 mL 2.8707 mL
    *Please refer to the solubility information to select the appropriate solvent.
    References

    Purity: 99.69%

    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.
    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

     

    Salutation

    Applicant Name *

     

    Email address *

    Phone number *

     

    Organization name *

    Department *

     

    Requested quantity *

    Country or Region *

         

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    Camptothecin
    Cat. No.:
    HY-16560
    Quantity:
    MCE Japan Authorized Agent: